Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune responses in cancer.

Jamila K Adam1, Bharti Odhav, Kanti D Bhoola

  • 1Department of Medical Science, Durban Institute of Technology (ML Sultan Campus), Durban, South Africa.

Pharmacology & Therapeutics
|June 14, 2003
PubMed
Summary

Cancer immunotherapy harnesses the body's innate and acquired immune systems to fight cancer. Combining strategies like vaccines and traditional drugs may offer the most effective long-term treatment for various cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship between clinical phenotype and kallikrein-kinin bioregulation in different forms of arthritis.

BMC musculoskeletal disorders·2023
Same author

Values of COVID-19 Self-Testing among Urban and Rural South Africans: A Cross-Sectional Survey.

Preventive medicine reports·2023
Same author

Kinin B1 Receptor Signaling in Skin Homeostasis and Wound Healing.

The Yale journal of biology and medicine·2020
Same author

In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against <i>Mycobacterium tuberculosis</i>.

Drug design, development and therapy·2020
Same author

Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification.

Antibiotics (Basel, Switzerland)·2019
Same author

Novel Series of Methyl 3-(Substituted Benzoyl)-7-Substituted-2-Phenylindolizine-1-Carboxylates as Promising Anti-Inflammatory Agents: Molecular Modeling Studies.

Biomolecules·2019

Area of Science:

  • Immunology
  • Oncology
  • Biotherapy

Background:

  • The immune system, comprising innate and acquired components, identifies and eliminates non-self molecules, including those on transformed cancer cells.
  • Antigenicity of transformed cells triggers specific immune responses, involving lymphocyte proliferation and the upregulation of immune factors.
  • Carcinomas elicit responses from both innate and acquired immune systems.

Purpose of the Study:

  • To explore immunotherapy as a novel approach to cancer treatment by enhancing the immune system's anti-cancer capabilities.
  • To review current therapeutic strategies in cancer immunotherapy.
  • To discuss the potential of combining different immunotherapeutic modalities and traditional therapies for improved outcomes.

Main Methods:

  • Review of existing research on cancer immunotherapy strategies.
  • Categorization of immunotherapies into monoclonal antibodies, immune response modifiers, and vaccines.
  • Exploration of combination therapies, including immunotherapy combinations and immunotherapy with chemotherapy.

Main Results:

  • Individual immunotherapies have shown promise in controlling cancer.
  • Combination strategies, particularly vaccines with other immunotherapies or traditional drugs, may yield superior results.
  • Enhancing chemotherapy efficacy with cytokines demonstrates the benefit of combined approaches.

Conclusions:

  • Multifaceted immunotherapeutic strategies are likely necessary to effectively combat cancer across diverse patient populations.
  • Combining immunotherapy with conventional treatments or other immunotherapies may lead to durable, long-lasting anti-tumor immune responses.
  • Optimizing immunotherapy combinations holds significant potential for advancing cancer care.

Related Experiment Videos